NAVOS
1. Target Overview & Investment Thesis
NAVOS is a 70-bed safety-net/medicaid heavy in KING, WA with $39.2M in net patient revenue and a -13.0% operating margin. The hospital serves a payer mix of 8.1% Medicare, 60.8% Medicaid, and 31.1% commercial.
Thesis: Turnaround. Our ML models identify $2.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -13.0% to -5.6% (+736bps).
| Net Revenue HCRIS | $39.2M |
| Current EBITDA COMPUTED | $-5.1M |
| Operating Margin COMPUTED | -13.0% |
| Occupancy HCRIS | 93.4% |
| Revenue / Bed COMPUTED | $560K |
| Net-to-Gross HCRIS | 36.7% |
| Distress Probability ML | 53.0% |
2. Market Context & Competitive Position
WA has 104 Medicare-certified hospitals with a median operating margin of -10.3%. The target's margin of -13.0% places it below the state median. Among 28 size-comparable peers (35-140 beds), the median margin is -9.7%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (35-140), prioritizing same-state peers. 28 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| NAVOS (Target) | WA | 70 | $39.2M | -13.0% |
| PHD#1 DBA SKAGIT VALLEY HOSPI | WA | 137 | $414.3M | -17.9% |
| ST. JOHN MEDICAL CENTER | WA | 122 | $335.0M | -4.4% |
| ST FRANCIS HOSPITAL | WA | 118 | $274.2M | -0.5% |
| PROVIDENCE CENTRALIA HOSPITAL | WA | 116 | $240.6M | -0.5% |
| OLYMPIC MEDICAL CENTER | WA | 78 | $237.9M | -12.2% |
| MULTICARE AUBURN MEDICAL CENTE | WA | 84 | $214.7M | -21.1% |
| PROV ST MARY MEDICAL CENTER | WA | 95 | $211.5M | -11.7% |
| ST ANTHONY HOSPITAL | WA | 112 | $200.1M | -4.3% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.9M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $823K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $784K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $776K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $477K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $25K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-5.1M |
| + RCM Uplift | +$2.9M |
| Pro Forma EBITDA | $-2.2M |
| Current Margin | -13.0% |
| Pro Forma Margin | -5.6% |
| WC Released (1x) | $1.5M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-7.8M | $-4.7M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-7.8M | $-7.7M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-7.0M | $-764K | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-7.0M | $-2.9M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-8.6M | $-16.6M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-8.6M | $-21.1M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Elevated Medicaid exposure (60.8%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| High | Elevated distress probability | Model estimates 53.0% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 28 hospitals with 35-140 beds
- Same-state prioritization (n=29)
- Comp margins: P25=-19.0% / P50=-9.7% / P75=-2.0%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.